Complete response of gallbladder cancer treated with gemcitabine and cisplatin chemotherapy combined with durvalumab: A case report and review of literature

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

661

Figures (1-4)

141

Sum=828

Publishing Process of This Article

Item

Count

Browse

Download

Sum=106

Jan 15, 2025 (publication date) through Mar 7, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastrointest Oncol. Jan 15, 2025; 17(1): 98433
Published online Jan 15, 2025. doi: 10.4251/wjgo.v17.i1.98433

Full Size Figure Download Figure

Figure 4 The timeline of the entire clinical course. GC-D: Gemcitabine, cisplatin, and durvalumab; PR: Partial response; CR: Complete response.

Citation: Chen K, Feng X, Shi Y, Li XL, Shi ZR, Lan X. Complete response of gallbladder cancer treated with gemcitabine and cisplatin chemotherapy combined with durvalumab: A case report and review of literature. World J Gastrointest Oncol 2025; 17(1): 98433
URL: https://www.wjgnet.com/1948-5204/full/v17/i1/98433.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i1.98433